What Caught Our Eye: ACA Repeal Debate, the Trump FDA Transition, and Cancer-Related Fatigue

What Caught Our Eye (WCOE), Week of January 9, 2017
Today we are re-launching our week-in-review What Caught Our Eye blog series, where we recap the cancer policy articles, studies, and stories that caught our attention.

Affordable Care Act

Two cancer survivors and friends of NCCS wrote an op-ed in STAT News: “ACA replacement must include affordable insurance for preexisting conditions.”

ACA replacement must include affordable insurance for preexisting conditions

Although the debate around repeal of the Affordable Care Act continues in Washington, as advocates for cancer survivors, we have a responsibility to rise above the politics and speak up for the needs of survivors.

Below are two articles that provide additional details about what is at stake for patients if the ACA is repealed:

https://healthaffairs.org/blog/2017/01/11/get-health-insurance-through-your-employer-aca-repeal-will-affect-you-too/
https://healthaffairs.org/blog/2017/01/04/the-aca-transformed-medicaid-enrollment-processes-rolling-them-back-would-wreak-havoc/

Food and Drug Administration (FDA) Leadership

Without question, the work of the Food and Drug Administration (FDA) to review and approve medications and treatments to ensure they are safe and effective is critical to cancer patients and their families. As such, here is an article that discusses some of the candidates to lead the FDA in the upcoming Trump Administration.

Two Silicon Valley insiders meet with Trump about heading FDA

Coping with Cancer

Bonnie Annis, a breast cancer survivor, looks at differentiating between normal fatigue and cancer-related fatigue, and the importance of discussing the issue with your doctor. Via Cure Magazine